1672-2809
2007 Issue 4
The change of the level of serum cortisol in severe hepatitis
GU Xi-bing;XU Yue-qing
GU Xi-bing;XU Yue-qing
..............page:302-303
..............page:272,288,303,310,312,314,318
bei fa dan kang lin chuang ying yong jin zhan
yu feng ; xiong jian ping
yu feng ; xiong jian ping
..............page:315-318
hplc ce ding qing fei he ji zhong huang zuo zuo de han liang
li yun jing ; chen jun mao ; zhang jin xing ; lu rong zhi ; xing jie ; wang qian lei
li yun jing ; chen jun mao ; zhang jin xing ; lu rong zhi ; xing jie ; wang qian lei
..............page:313-314
hplc ce ding shan huang jin gao zhong yan suan xiao zuo jian de han liang
liu na ; deng hong ; lin hua qing ; zhang shu
liu na ; deng hong ; lin hua qing ; zhang shu
..............page:311-312
..............page:308-310
zhu she yong tou zuo zuo lin na yu li ba wei lin zhu she ye zai shu ye zhong pei wu de wen ding xing kao cha
wei shi yong
wei shi yong
..............page:306-307
..............page:304-306
The role of PPARγon the development of nonalcoholic steatohepatitis related fibrosis in rats
WANG Xiao-min;CHEN Dong-feng
WANG Xiao-min;CHEN Dong-feng
..............page:298-302
Observation on the effect of the anti-fibrosis treatment with Interferon alpha
zhang yu ; chen huan yong ; zhu si he ; lu bao ling ; cai hua feng ; wang fei
zhang yu ; chen huan yong ; zhu si he ; lu bao ling ; cai hua feng ; wang fei
..............page:294-297
Study on the compliance of anti-hypertension No.0 in treatment patient with essential hypertension in community
ZHU Xin-rong;ZHEN Jun;LIN Zhong
ZHU Xin-rong;ZHEN Jun;LIN Zhong
..............page:292-293,297
Drug therapy and assessment of alcoholic liver disease
LIU Qin;Cheng Ming-Liang
LIU Qin;Cheng Ming-Liang
..............page:289-291
..............page:285-288
Study actuality of nonalcoholic fatty liver with fibrosis
MA Xiong;WEI Jue
MA Xiong;WEI Jue
..............page:282-285
Evaluation about drug therapy of hepaticencephalopath
CHENG Dong-feng;AI Zheng-Lin
CHENG Dong-feng;AI Zheng-Lin
..............page:279-281
Drug therapy and assessment of hepatorenal syndrome
NIE Qing-hu;LUO Xin-dong
NIE Qing-hu;LUO Xin-dong
..............page:276-278,291
Drug therapy and assessment of hepatocirrhosis ascites
ZHAO Cai-yan;YAN Wen-zhao
ZHAO Cai-yan;YAN Wen-zhao
..............page:273-276
Drug therapy and assessment of hepatocirrhosis with portal hypertension
FANG Cui-yan;FAN Jian-gao
FANG Cui-yan;FAN Jian-gao
..............page:270-272
Actuality and prospect of clinic study on liver fibrosis
CUI Yan;JIA Ji-dong
CUI Yan;JIA Ji-dong
..............page:267-270
gan xian wei hua zhen duan ji liao xiao ping gu gong shi
zhong hua gan zang bing xue hui gan xian wei hua xue zu
zhong hua gan zang bing xue hui gan xian wei hua xue zu
..............page:265-266
gan xian wei hua zhong xi yi jie he zhen liao zhi nan
zhong guo zhong xi yi jie he xue hui gan bing zhuan ye wei yuan hui
zhong guo zhong xi yi jie he xue hui gan bing zhuan ye wei yuan hui
..............page:260-264
..............page:257-260